OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00595057

Isu Chemical Co Ltd

Commodity ChemicalsVerified

Isu Chemical Co Ltd exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 4.42, significantly above the typical thresholds for chemical industry firms. The company's liquidity position is constrained, as evidenced by a current ratio of 0.81 and negative free cash flow of -45.63 billion KRW. The negative operating cash flow of -4.30 billion KRW and a net cash position that is negative after subtracting total debt further highlight the company's liquidity challenges. Profitability metrics are sharply negative, with a return on equity of -32.33% and a return on assets of -3.46%. These figures indicate a significant underperformance relative to the industry's preferred metrics, which typically emphasize stable gross margins and positive operating returns. The company's net loss of 31.07 billion KRW contrasts with the industry's median profitability, suggesting operational inefficiencies or market pressures. The company's revenue is derived from petrochemical products, biopharmaceuticals, and real estate ventures, though the input data does not specify the relative contribution of each segment. Geographically, the company operates in both domestic and overseas markets, but the data does not provide a breakdown of revenue by region. This lack of transparency limits the ability to assess geographic diversification and potential concentration risks. The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. However, the negative net income and free cash flow suggest a challenging operating environment. The capital expenditure of -28.95 billion KRW indicates ongoing investment, but the negative operating cash flow raises questions about the sustainability of these investments without external financing. Risk factors include medium liquidity risk, as the company's cash and equivalents of 75.82 billion KRW are insufficient to cover its long-term debt of 425.19 billion KRW. The risk assessment also notes a low dilution potential, but the negative net income and free cash flow suggest the company may need to raise additional capital in the near term. The dilution_expected_timeframe is not specified, but the adjustments_applied in custom_valuations indicate potential capital structure changes. Recent events, including filings and transcripts, are not detailed in the input data, limiting the ability to assess management commentary or strategic shifts. The absence of recent events data suggests a lack of public disclosures or significant operational changes in the near term.

30-day price · 005950+2250.00 (+28.1%)
Low$7500.00High$12700.00Close$10260.00As of14 May, 00:00 UTC
Profile
CompanyIsu Chemical Co Ltd
Ticker005950.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Isu Chemical Co Ltd is a Korea-based company engaged in the manufacturing and sales of petrochemical products, smart farms, apartments, and public buildings, as well as the biopharmaceutical business.

Classification. Isu Chemical Co Ltd is classified in the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Isu Chemical Co Ltd exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 4.42, significantly above the typical thresholds for chemical industry firms. The company's liquidity position is constrained, as evidenced by a current ratio of 0.81 and negative free cash flow of -45.63 billion KRW. The negative operating cash flow of -4.30 billion KRW and a net cash position that is negative after subtracting total debt further highlight the company's liquidity challenges. Profitability metrics are sharply negative, with a return on equity of -32.33% and a return on assets of -3.46%. These figures indicate a significant underperformance relative to the industry's preferred metrics, which typically emphasize stable gross margins and positive operating returns. The company's net loss of 31.07 billion KRW contrasts with the industry's median profitability, suggesting operational inefficiencies or market pressures. The company's revenue is derived from petrochemical products, biopharmaceuticals, and real estate ventures, though the input data does not specify the relative contribution of each segment. Geographically, the company operates in both domestic and overseas markets, but the data does not provide a breakdown of revenue by region. This lack of transparency limits the ability to assess geographic diversification and potential concentration risks. The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. However, the negative net income and free cash flow suggest a challenging operating environment. The capital expenditure of -28.95 billion KRW indicates ongoing investment, but the negative operating cash flow raises questions about the sustainability of these investments without external financing. Risk factors include medium liquidity risk, as the company's cash and equivalents of 75.82 billion KRW are insufficient to cover its long-term debt of 425.19 billion KRW. The risk assessment also notes a low dilution potential, but the negative net income and free cash flow suggest the company may need to raise additional capital in the near term. The dilution_expected_timeframe is not specified, but the adjustments_applied in custom_valuations indicate potential capital structure changes. Recent events, including filings and transcripts, are not detailed in the input data, limiting the ability to assess management commentary or strategic shifts. The absence of recent events data suggests a lack of public disclosures or significant operational changes in the near term.
Key takeaways
  • Isu Chemical Co Ltd is highly leveraged, with a debt-to-equity ratio of 4.42, indicating significant financial risk.
  • The company is unprofitable, with a return on equity of -32.33% and a net loss of 31.07 billion KRW.
  • Liquidity is constrained, as evidenced by a current ratio of 0.81 and negative free cash flow.
  • The company's growth trajectory is unclear, with no specific numeric deltas provided for the current or next fiscal year.
  • The risk assessment highlights medium liquidity risk and potential capital structure changes.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$1.66T
Gross profit$125.57B
Operating income$1.97B
Net income-$31.07B
R&D
SG&A
D&A
SBC
Operating cash flow-$4.30B
CapEx-$28.95B
Free cash flow-$45.63B
Total assets$897.71B
Total liabilities$801.60B
Total equity$96.11B
Cash & equivalents$75.82B
Long-term debt$425.20B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$96.11B
Net cash-$349.37B
Current ratio0.8
Debt/Equity4.4
ROA-3.5%
ROE-32.3%
Cash conversion14.0%
CapEx/Revenue-1.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric005950Activity
Op margin0.1%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-1.9%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin7.6%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity442.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-14 00:44 UTC#c603a512
Source: analysis-pipeline (hybrid)Generated: 2026-05-14 00:48 UTCJob: e491ad77